Skip to content

Ayurvedic management of non proliferative diabetic retinopathy (madhumeha janya timira) with pancha tikta panchaprasrutika basti, sarivadi anjana, vasakadi kwatha

AYURVEDIC MANAGEMENT OF NON-PROLIFERATIVE DIABETIC RETINOPATHY (MADHUMEHAJANYA TIMIRA) WITH PANCHATIKTA PANCHAPRASRUTIKA BASTI, SARIVADI ANJANA AND VASAKADI KWATHA â?? AN OPEN LABEL RANDOMISED CONTROLLED CLINICAL STUDY - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/055593
Enrollment
50
Registered
2023-07-24
Start date
Unknown
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H350- Background retinopathy and retinalvascular changes

Interventions

None listed

Sponsors

Government Akhandanand Ayurved College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients willing for present treatment. 2. Age group between 18-70 years of either sex having diabetes mellitus. 3. Patients having moderate to good glycemic control (FBS 4. The patient with detectable ophthalmoscopic features of NPDR with or without visual disturbances 5. The patient presenting with signs and symptoms of NPDR with or without diabetic macular oedema [DME] 6. Patients of NPDR who have undergone modern medical management and Laser Photocoagulation therapy previously for the same but with persisting symptoms and/or signs are also included in the study.

Exclusion criteria

Exclusion criteria: 1. Age less than 18 years and more than 70 years 2. Proliferative diabetic retinopathy 3. Contraindicated for Anjana and Basti 4. DR associated with pregnancy 5. Any media opacity hampering ophthalmoscopic examination like iridocyclitis, corneal opacity, mature cataract, etc. 6. Vision hampering other diseases like, glaucoma, ARMD etc. 7. Chronic debilitating diseases like HIV, Carcinoma etc.

Design outcomes

Primary

MeasureTime frame
to reduce difficulty in vision, blurred vision, dark adaptation, diminished visionTimepoint: 60 days

Secondary

MeasureTime frame
To improve quality of life with improved vision & slowing down process of conversion of non proliferative diabetic retinopathy to proliferative diabetic retinopathy.Timepoint: 90 days

Countries

India

Contacts

Public ContactVd Kundan Patel

Government Akhandanand Ayurved College

drkundan14@yahoo.com9228717075

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026